Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 14151 - 14175 of 14985 in total
Experimental
INS316 belongs to the family of drugs called nucleoside triphosphates.It is studied in the diagnosis of lung diseases, including lung cancer. It is selective P2y2 receptor antagonists claimed to be useful as anti-inflammatory agents.
Investigational
Matched Description: … of lung diseases, including lung cancer. ... INS316 belongs to the family of drugs called nucleoside triphosphates.It is studied in the diagnosis …
CHGN111 is an inhibitor of the mitochondrial enzyme CLK-1 which is a demethoxyubiquinone hydroxylase. Numerous parameters of mitochondrial function are altered when the activity of CLK-1 is reduced, which results in a decrease of ROS at critical cellular sites, as well as in a decrease of systemic oxidative stress. It...
Investigational
Matched Description: … Numerous parameters of mitochondrial function are altered when the activity of CLK-1 is reduced, which ... results in a decrease of ROS at critical cellular sites, as well as in a decrease of systemic oxidative ... CHGN111 is an inhibitor of the mitochondrial enzyme CLK-1 which is a demethoxyubiquinone hydroxylase. …
R1295 is an integrin antagonist currently in clinical trials for the treatment of rheumatoid arthritis. Integrins are associated to the pathology seen in some of the autoimmune diseases such as rheumatoid arthritis.
Investigational
Matched Description: … R1295 is an integrin antagonist currently in clinical trials for the treatment of rheumatoid arthritis ... Integrins are associated to the pathology seen in some of the autoimmune diseases such as rheumatoid …
AZD6280 has been used in trials studying the basic science of Anxiety.
Investigational
Matched Description: … AZD6280 has been used in trials studying the basic science of Anxiety. …
Seladelpar (MBX-8025) has been used in trials studying the treatment of Hyperlipidemia.
Investigational
Matched Description: … Seladelpar (MBX-8025) has been used in trials studying the treatment of Hyperlipidemia. …
Candoxatril is the orally-active prodrug of candoxatrilat (UK-73967), a potent neutral endopeptidase (NEP) inhibitor.
Experimental
Matched Description: … Candoxatril is the orally-active prodrug of candoxatrilat (UK-73967), a potent neutral endopeptidase …
Experimental
BMS-564929 is an investigational therapeutic agent built to be a selective androgen receptor modulator (SARM). So far, it has been developed by Bristol-Myers Squibb for the symptomatic treatment of andropause.
Experimental
Matched Description: … So far, it has been developed by Bristol-Myers Squibb for the symptomatic treatment of andropause. …
Experimental
Experimental
Investigational
MK-4965 is an HIV-1 reverse transcriptase inhibitor.
Experimental
Displaying drugs 14151 - 14175 of 14985 in total